Tag

Tag: Antibody-drug conjugates

adc therapeutics antibody-drug conjugates blood cancer

09/07/2019 2 mins

Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy

synaffix adc antibody-drug conjugate glythera

10/04/2019 1 min

Dutch Antibody-Drug Conjugates Licensed to Chinese Pharma for up to €111M

Basel 2018 - Ulf Grawunder - Immuno-oncology

25/10/2018 5 mins

Mastering the Competitive World of Immuno-oncology

29/06/2018 2 mins

Update: Yet Another ADC Company Makes Bank, This Time in Series B

11/12/2017 2 mins

New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients

21/11/2017 1 min

German Biotech Reels in €34M for its Cancer-Killing Technology

04/10/2017 5 mins

4th-Generation ADCs: Meet the Swiss Startup Perfecting the Technology

synaffix adc antibody-drug conjugate glythera

20/09/2017 1 min

New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer

16/06/2017 2 mins

Swiss ADCs Show Impressive Responses for Lymphoma in Phase I

01/06/2017 3 mins

Next-Gen Drug Conjugates Bank €46M in Series B with American Investors

24/02/2017 5 mins

What are the Current Challenges in the Booming Field of ADCs?

23/02/2017 4 mins

In the Age of Biological Therapeutics, Chemists move to ADCs

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.